Showing results (31-40 of 176) with videos related to
Sort By:
Pageof 18
Transplantation Proceedings|December 10, 2016
Successful Short-Term Intravenous Treatment of Disseminated Nocardia farcinica Infection with Severe Hyponatremia After Kidney Transplantation: A Case ReportA L Herzog, C Wanner, K LopauCardiology|January 1, 1991
Hyperlipoproteinemia in chronic renal failure: pathophysiological and therapeutic aspectsC Wanner, K Frommherz, W H HörlJPEN. Journal of Parenteral and Enteral Nutrition|September 1, 1987
Proteinases in catabolism and malnutritionW H Hörl, C Wanner, P SchollmeyerJournal of Nephrology|January 19, 2002
Lipid changes and statins in chronic renal insufficiency and dialysisC Wanner, V Krane, T Metzger, et al.Advances in Experimental Medicine and Biology|January 1, 1988
Evidence for the role of proteinases in uremic catabolismR M Schaefer, M Teschner, G Peter, et al.American Journal of Nephrology|January 1, 1987
Evidence for reduced catabolism by the antiglucocorticoid RU 38486 in acutely uremic ratsR M Schaefer, M Teschner, P Kulzer, et al.Mineral and Electrolyte Metabolism|January 1, 1988
Reduction of muscle protein degradation by leupeptin in acutely uremic ratsR M Schaefer, M Teschner, G Peter, et al.Kidney International. Supplement|November 14, 1997
Inflammation, dyslipidemia and vascular risk factors in hemodialysis patientsC Wanner, J Zimmermann, T Quaschning, et al.Cellular and Molecular Biology (Noisy-Le-Grand, France)|December 10, 1998
Impairment of endothelial function induced by glyc-oxidized lipoprotein a [Lp(a)]J Galle, B Winner, E Conzelmann, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 29, 2001
Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular diseaseT Quaschning, V Krane, T Metzger, et al.Pageof 18